Treace Medical Concepts, Inc. Payments of Financing Costs
Treace Medical Concepts, Inc. (TMCI) reported Payments of Financing Costs of $8.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2021-05-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2021-05-25
- Treace Medical Concepts, Inc. payments of financing costs for the quarter ending 2020-03-31 was $8.00K.
| Period end | Payments of Financing Costs 3 month |
|---|---|
| 2020-03-31 | $8.00K 10-Q · filed 2021-05-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |